Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-3-7
pubmed:abstractText
A major cause of death in patients with severe hemorrhagic shock following trauma is the subsequent occurrence of multiple organ failure due to tissue hypoxia. Early administration of an oxygen carrier may reduce the occurrence of organ failures and improve survival. It may also reduce the need of blood products.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0342-4642
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
378-85
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12541156-Adolescent, pubmed-meshheading:12541156-Adult, pubmed-meshheading:12541156-Aged, pubmed-meshheading:12541156-Aged, 80 and over, pubmed-meshheading:12541156-Aspirin, pubmed-meshheading:12541156-Blood Substitutes, pubmed-meshheading:12541156-European Union, pubmed-meshheading:12541156-Female, pubmed-meshheading:12541156-Fluid Therapy, pubmed-meshheading:12541156-Hemoglobins, pubmed-meshheading:12541156-Humans, pubmed-meshheading:12541156-Male, pubmed-meshheading:12541156-Middle Aged, pubmed-meshheading:12541156-Multiple Organ Failure, pubmed-meshheading:12541156-Prospective Studies, pubmed-meshheading:12541156-Shock, Hemorrhagic, pubmed-meshheading:12541156-Statistics, Nonparametric, pubmed-meshheading:12541156-Survival Rate, pubmed-meshheading:12541156-Trauma Severity Indices, pubmed-meshheading:12541156-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" multicenter study.
pubmed:affiliation
Klinik für Anästhesiologie und Operative Intensivmedizin, Campus Virchow-Klinikum, Charité, Humboldt Universität, Augustenburger Platz 1, 13353 Berlin, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Comment, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study